President Donald Trump has announced plans to impose tariffs on American pharmaceutical imports during a media briefing at the White House. Initially, a 'small tariff' will be introduced, rising to 150% over 18 months and subsequently reaching 250%. This strategy is designed to promote domestic production.
Trump also mentioned impending tariffs on semiconductors and chips, expected 'next week or so,' though he provided limited details. Currently, the U.S. is conducting a national security review of the pharmaceutical sector. Industry leaders have been warned to brace for potential sector-specific tariffs, yet a release date for this review's outcomes remains unspecified.
Also Read: 'I'll look into it...', when India reflected on Russian imports, Trump's introspection awaited
Frustrated with Russian oil imports, Trump now intends to impact India's key sector - pharmaceuticals. The U.S. faces a trade deficit of $115.5 billion in pharmaceutical products. The Trump administration hinted at balancing this deficit with tariffs by 2026, though Trump has already mapped out the path for this year. The U.S. is the world's largest pharmaceutical importer and second-largest exporter.
Countries Supplying Pharmaceuticals to the U.S.
In 2024, U.S. imports of medicinal and pharmaceutical products totaled $234 billion. Ireland led among the top 10 exporters ($65.7 billion, 28.1% of total imports), followed by Switzerland ($19.3 billion, 8.2%) and Germany ($17.4 billion, 7.4%). Additional key suppliers included Singapore, India, Belgium, Italy, China, the UK, and Japan, with Indian imports amounting to $13 billion, representing 6% of the overall imports.
Also Read: 'Don't sour ties with strong allies like India...' – Nikki Haley on Trump's Tariff Threats
31% of India's Exports to the U.S.
India primarily exports its pharmaceutical products, particularly generic drugs, to the U.S., making up over 31% of its total pharmaceutical exports. In the fiscal year 2024, India's pharmaceutical exports to the U.S. were valued at $8.73 billion. Plainly, should Trump finalize tariffs on this sector, India could face significant export losses.
